Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camillo Ribi

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
Annals of the New York Academy of Sciences|May 16, 2018
Eosinophilic esophagitis: latest insights from diagnosis to therapyAlain Schoepfer, Carine Blanchard, Heather Dawson, et al.
BMC Immunology|March 30, 2017
Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS)Benjamin Chaigne, Carlo Chizzolini, Thomas Perneger, et al.
Genes|May 27, 2023
ITGAM rs1143679 Variant in Systemic Lupus Erythematosus Is Associated with Increased Serum Calcification PropensityMatthieu Halfon, Li Zhang, Driss Ehirchiou, et al.
Autoimmunity Reviews|August 26, 2014
Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factorsMaxime Samson, Xavier Puéchal, Hervé Devilliers, et al.
Frontiers in Immunology|December 3, 2019
Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic SiteKinga Csorba, Lucia A Schirmbeck, Eylul Tuncer, et al.
Revue Medicale Suisse|May 16, 2009
[Towards the Swiss systemic lupus erythematosus cohort study (SSCS)]Carlo Chizzolini, Clemens D Cohen, Ute Eisenberger, et al.
Autoimmunity Reviews|October 29, 2013
Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factorsMaxime Samson, Xavier Puéchal, Hervé Devilliers, et al.
Lupus|June 21, 2021
Neuro-psychiatric manifestations in patients with systemic lupus erythematosus: A systematic review and results from the Swiss lupus cohort studyAline L Meier, Nicolas S Bodmer, Carla Wirth, et al.
Frontiers in Immunology|May 23, 2022
SLAMF Receptor Expression Identifies an Immune Signature That Characterizes Systemic Lupus ErythematosusMorgane Humbel, Florence Bellanger, Alice Horisberger, et al.
Journal of Translational Autoimmunity|October 24, 2024
Extrafollicular CD19<sup>low</sup>CXCR5<sup>-</sup>CD11c<sup>-</sup> double negative 3 (DN3) B cells are significantly associated with disease activity in females with systemic lupus erythematosusCarlo Chizzolini, Jean-Charles Guery, Fanny Noulet, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Annals of the New York Academy of Sciences|May 16, 2018
Eosinophilic esophagitis: latest insights from diagnosis to therapyAlain Schoepfer, Carine Blanchard, Heather Dawson, et al.
BMC Immunology|March 30, 2017
Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS)Benjamin Chaigne, Carlo Chizzolini, Thomas Perneger, et al.
Genes|May 27, 2023
ITGAM rs1143679 Variant in Systemic Lupus Erythematosus Is Associated with Increased Serum Calcification PropensityMatthieu Halfon, Li Zhang, Driss Ehirchiou, et al.
Autoimmunity Reviews|August 26, 2014
Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factorsMaxime Samson, Xavier Puéchal, Hervé Devilliers, et al.
Frontiers in Immunology|December 3, 2019
Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic SiteKinga Csorba, Lucia A Schirmbeck, Eylul Tuncer, et al.
Revue Medicale Suisse|May 16, 2009
[Towards the Swiss systemic lupus erythematosus cohort study (SSCS)]Carlo Chizzolini, Clemens D Cohen, Ute Eisenberger, et al.
Autoimmunity Reviews|October 29, 2013
Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factorsMaxime Samson, Xavier Puéchal, Hervé Devilliers, et al.
Lupus|June 21, 2021
Neuro-psychiatric manifestations in patients with systemic lupus erythematosus: A systematic review and results from the Swiss lupus cohort studyAline L Meier, Nicolas S Bodmer, Carla Wirth, et al.
Frontiers in Immunology|May 23, 2022
SLAMF Receptor Expression Identifies an Immune Signature That Characterizes Systemic Lupus ErythematosusMorgane Humbel, Florence Bellanger, Alice Horisberger, et al.
Journal of Translational Autoimmunity|October 24, 2024
Extrafollicular CD19<sup>low</sup>CXCR5<sup>-</sup>CD11c<sup>-</sup> double negative 3 (DN3) B cells are significantly associated with disease activity in females with systemic lupus erythematosusCarlo Chizzolini, Jean-Charles Guery, Fanny Noulet, et al.
Pageof 13